Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Valensa Launches Omega Joe(TM) ALA as a Daily Source of Plant-Based ALA Omega-3

Super Critical DeepExtract(R) of Perilla Responds to Research Showing ALA Supplementation Offers Solid Support for Cardiovascular Health and Overall Well-Being


News provided by

Valensa International

Oct 22, 2010, 08:10 ET

Share this article

Share toX

Share this article

Share toX

LAS VEGAS, Oct. 22 /PRNewswire/ -- Valensa International (Eustis, FL USA) announced today that it has launched a new high-quality, supercritical CO2 extract of perilla as part of its expanding line of Omega-3 ingredients. Called Omega Joe(TM) ALA, the new ingredient is made from select grade seeds of the Asian Perilla frutescens plant and is extracted using Valensa's proprietary Deep Extract(R) extraction process. Omega Joe ALA has the highest ratio of Omega-3 to Omega-6 fatty acids of any known seed oil -- an astounding 6:1 -- and typically a 50-60% alpha linolenic acid (ALA) content. The new ingredient has been launched to help people lower their Omega-6 to Omega-3 (linoleic acid to alpha linolenic acid) from the typical Western unhealthy level of 30:1 or higher down to a targeted and healthier 4:1 ratio. There is increasing awareness of the ability of ALA Omega-3 fatty acids to address cardiovascular health and other conditions related to chronic inflammation resulting from the over consumption of Omega-6 fatty acids. The new ingredient is called "Omega Joe" because it is designed to be taken daily -- to offset the large amounts of Omega-6 fatty acids Westerners consume via meats and refined vegetable oils, such as corn and soy, that are used in most of the snack foods, cookies, crackers, and in other processed foods. The new Omega Joe ALA is a premium ingredient that features Valensa's potent O2B(R) peroxidation blocker technology, meaning it has an extended shelf life compared to other similar extracts -- up to two years.

According to Dr. Rudi E. Moerck, President and CEO of Valensa, research shows that inflammation resulting from a high linoleic acid to alpha linoleic acid ratio (LA to ALA) from dietary sources is the cause of many of the health conditions that cost society billions of dollars to treat. "Studies on the ratio of LA to ALA in diets show dramatic evidence that the nations where that ratio is high have much greater incidence of mortality from cardiovascular disease. Research also suggests that a number of health conditions that are prevalent in Western nations such as diabetes, asthma, and certain forms of cancer, obesity and even mental health are believed to stem from inflammation in the body related to 'modern' eating habits. This suggests that regular supplementation with a plant-based Omega-3 such as chia, flax or Omega Joe ALA should start in early years and become a lifelong routine for people having 'typical' Western diets," he said. "On the cardiovascular health front alone, low levels of ALA consumption have been reported to have profound effects either before or after myocardial infarction (MI). The scientific literature indicates that ALA is itself a very potent down-regulator of the LA-AA pro-inflammatory cascade. Published biological rate studies indicate that ALA, as a substrate for the key rate limiting step in the shared biological cascade, is actually four times faster than LA conversion. We think this research is too important to be ignored by the natural products industry," he added.

Plant-based Omega-3s and Cardiovascular Health

A new study published in the Journal of Lipid Research in July 2010 showed that that continuous exposure to a high-fat diet combined with a high Omega-6 to Omega-3 ratio over generations triggers a discrete and steady increase in inflammatory stimuli that lead to chronic health conditions such as cardiovascular disease and diabetes, accompanied by enhancement of fat mass -- or obesity. Previous studies have shown:

  • A 16% reduction in the risk of CVD for every 1 gm/day increase in dietary ALA in a study of 45,000 men over a 14 year period.
  • A 45% reduction in the risk of CVD in a study of 76,000 women over a 10 yr period that compared a group that received 1.4 gm/day of ALA compared to the control group at 0.7 gm/d of ALA.
  • Several controlled clinical trials found that increased ALA intake decreased serum concentrations of C-reactive protein, a marker strongly associated with risk of CV events such as MI or Stroke.
  • Another study that showed that the addition of ALA to a Mediterranean diet following an initial MI decreased mortality by 70%.

The Plant-based versus Animal-based Omega-3 Controversy

Research that has been done to date on the health benefits of Omega-3s is both remarkable and extensive. Publicity, however, has been primarily focused on fish oil that contains triacylglyceride-bound EPA and DHA, in spite of the fact that ALA is the only Omega-3 with an established Dietary Reference Intake (DRI) value. Instead, there has been a good deal of publicity that has cast doubt about the health benefits of ALA -- citing its inefficient conversion into DHA and EPA. According to Moerck, this is simply not true by scientific standards. "Solid studies have shown excellent conversion of ALA from seed oil to EPA and DPA, the immediate precursor to DHA. Clearly then, this explains why people who have not been exposed to fatty fish containing EPA and DHA have fully functional immune systems, balanced innate and adaptive immune systems, functional brains, nerve systems and eyes despite the lack of food-based EPA and DHA where DHA and EPA play major roles at the cellular membrane level. This is why the Institute of Medicine publishes an RDI for ALA and LA as essential fatty acids but has not published RDIs for EPA and DHA," he said.

Valensa offers one of the broadest plant-based Omega-3 portfolios on the market. These products are differentiated to target different health benefits and differing requirements by marketers in both the supplement and functional food areas. Today, Valensa Omega-3 brands and offerings include Omega Joe ALA(R) Perilla Extract, Tresalbio(TM) Supercritical Chia Seed Extract, ChiaGold(TM) Stabilized Chia Seed Oil, ChiaMax(TM) Low-Fat Whole Grain, Z-Omega(TM)3-6-9, Cranberol(R) Cranberry Seed Extract and AstaCran(R) Astaxanthin-Cranberry Seed Extract. The new Omega Joe ALA(R) Perilla seed extract focuses on the delivery of high quality ALA efficiently in a form that can become a part of a daily supplementation routine because it offers higher levels of ALA than either chia or flax. Says Moerck, "Today, we have the chance for a daily 'cup of joe' -- Omega Joe ALA -- to counteract the issues stemming from our fast-food Western diet."

According to Moerck, it is time for ALA from plant-based Omega-3s to take its position alongside DHA and EPA as an extremely important opportunity to improve human health. "Beyond a broad range of demonstrable health benefits, plant-based Omega-3s are inherently lower in heavy metals and are sustainable -- while conventional fish oils are problematic. They offer better consumer compliance from a taste and ingestion standpoint. They have the potential to be lower in cost and can be provided to a broader section of the population. Most importantly, they potentially offer support for some of the chronic health issues we associate with the Western lifestyle," he said. "Michael Pollan, in The Omnivore's Dilemma, points out the effects of corn monoculture on the Western diet and related health issues. This stems, he says, directly from the lack of balance between ingested Omega-3s and Omega-6s. It would not be unfair to say that the day a child has their first Happy Meal(R) is the day they should start supplementing with plant-based Omega-3," he added. For more information on Omega Joe ALA, visit http://www.valensa.com.

For further information contact:

Dr. Rudi Moerck, President & CEO

Voice: 352-357-2004 ext. 701

Fax: 352-483-2095

http://www.valensa.com

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

SOURCE Valensa International

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.